
Sai Life Sciences Limited has informed the Exchange regarding a press release dated August 28, 2025, titled "Press Release regarding commencement of second phase of production block at unit IV Bidar Facility.".
Filed with NSE · · 3 pages · English
The facility is designed for large-scale production and has been approved by major global regulatory agencies, ensuring compliance and quality. The announcement emphasizes the company's commitment to supporting its clients in bringing new medicines to market efficiently.
Written by 6ix AI from the company’s filing. How 6ix writes summaries

Sai Life Sciences Limited has informed the Exchange regarding a press release dated August 28, 2025, titled "Press Release regarding commencement of second phase of production block at unit IV Bidar Facility.".
Follow SAI Life Sciences into a list and get an email when it puts out news.
Follow SAI Life Sciences